LICENSURE State of Michigan License, 1998 State of New York License, 2000
EDUCATION Wayne State University Medical School, Detroit, MI, 1990-1994 Honors in Internal Medicine Clinical Honors in Surgery, Obstetrics/Gynecology, Family Practice
University of Michigan, College of Literature, Science, and the Arts, Ann Arbor, MI, 1986-1990 B.S. Psychology, 1990 Class Honors 1987, 1988
TRAINING Intern in General Surgery, William Beaumont Hospital, Royal Oak, MI, 1994-1995
Advanced Microsurgery Course, Henry Ford Hospital, Detroit, MI, 1997
Resident in General Surgery, William Beaumont Hospital, Royal Oak, MI, 1995-1997, 1998-2000
Resident in Cardiothoracic Surgery, New York University Medical Center, New York, NY, 2000-2002
RESEARCH Research Fellow, Thoracic Surgery Myocellular Biology Research Laboratory Steven F. Bolling, M.D. Section of Thoracic Surgery Department of Surgery, University of Michigan Medical School, Ann Arbor, MI, 1997-1998
Research Assistant, Department of Surgery University of Michigan Medical Center Jeremiah Turcotte, M.D. Auxiliary Hepatic Transplantation Project, 1988, 1989
Research Assistant, Department of Surgery, Section of Vascular Surgery, University of Michigan Medical Center James Stanley, M.D. , Jobst Research Laboratories, 1991, 1993 Molecular Basis for Various Vasoactive and Fibroproliferative Responses of the Vessel Wall to Injury During Endarterectomy or Bypass Procedures Gene Transfer and Expression as a Means of Inhibiting Neointimal Proliferation
1. Schwartz CF, Wei RQ, Lin H, Bolling SF. The role of costimulation in cardiac xenograft survival. Owen H. Wangensteen Surgical Forum 1998, American College of Surgeons 84th Annual Clinical Congress 1998; XLIX:376-377.
2. Wei RQ, Schwartz CF, Lin H, Chen GH, Bolling SF. Anti-TNF antibody modulates cytokine and MHC expression in cardiac allografts. Journal of Surgical Research 81:123-128 1999.
3. Walters J, Schwartz CF, Monaghan H, Watts J, Shlafer GJ, Deeb GM, Bolling SF. Long term outcome following case management after coronary artery bypass surgery. Journal of Cardiac Surgery 13:123-128 1998.
4. Georges AJ, Schwartz CF, Kilgore KS, Gallagher MA, Bolling SF. Delta opioid receptor induced myocardial protection. Owen H. Wangensteen Surgical Forum 1998, American College of Surgeons 84th Annual Clinical Congress 1998; XLIX: 196-197.
5. Schwartz CF, Kilgore KS, Homeister JW, Levy BA, Lucchesi BR, Bolling SF. Increased rat cardiac allograft survival by the glycosaminoglycan pentosan polysulfate. Journal of Surgical Research 86:24-28 1999.
6. Kilgore KS, Schwartz CF, Gallagher MA, Steffen RP, Mosca RS, Bolling SF. RSR13, a synthetic allosteric modifier of hemoglobin, improves myocardial recovery following hypothermic cardiopulmonary bypass. Circulation 100[suppl. II]:351-356 1999.
7. Schwartz CF, Georges AJ, Gallagher M, Yu L, Kilgore KS, Bolling SF. Delta opioid receptors and low temperature myocardial protection. Annals of Thoracic Surgery 68:2089-2092 1999. 8. Bolling SF, Schwartz CF, Gallagher M, Bach DS. Annular motion and mitral valve reconstruction. Abstract submitted to Journal of Heart Valve Disease.
9. Bolling SF, Schwartz CF, Pagani FD, Bach DS. Transmitral myomectomy and mitral valve replacement for hypertrophic obstructive cardiomyopathy. Abstract submitted to Journal of Heart Valve Disease.
10. Bolling SF, Badhwar V, Schwartz CF, Oeltgen PR, Kilgore K, Su TP. Opioids confer myocardial tolerance to ischemia: Interaction of delta opioid agonists and antagonists. Journal of Thoracic and Cardiovascular Surgery 122:476-481 2001.
Schwartz CF, Bolling SF. Mitral Valve Endocarditis. In Endocarditis, Multidisciplinary Approach to Modern Treatment, edited by AA Vlessis and SF Bolling. ã1999 Futura Publishing Co., Armonk, NY.
Schwartz, CF, Grossi EA, Sharony R, Saunders PC, Colvin SB, Galloway AC. Advances in Mitral Valve Reconstruction. In Current Therapy in Thoracic and Cardiovascular Surgery, edited by DE Cameron and SC Yang. ã2003 Elsevier Publishing Co.,
Schwartz CF, Galloway AC. Coronary Artery Disease. In Surgical Decision Making, edited by RC McIntyre, GV Steigmann, and B Eisman. ©2003 Elsevier Publihing Co.
1. The role of costimulation in cardiac xenograft survival, American College of Surgeons 53rd Annual Session of the Owen H. Wangensteen Surgical Forum, October 27, 1998, Orlando, Florida.
2. The synthetic allosteric modifier (RSR 13) improves post ischemic recovery, 71st Scientific Session of the American Heart Association, November 12, 1998, Dallas, Texas.
3. Prolongation of rat cardiac allograft survival by the glycosaminoglycan pentosan polysulfate, Association for Academic Surgery 32nd Annual Meeting, November 19, 1998, Seattle, Washington.
4. Delta opioid receptors and low temperature myocardial protection, The Society of Thoracic Surgeons 35th Annual Meeting, January 26, 1999, San Antonio, Texas.
5. Delta opioid agonist/antagonist activity and ischemic tolerance, 72nd Scientific Session of the American Heart Association, November 9, 1999, Atlanta, Georgia.
PRESENTATIONS
Introduction to Aortic and Mitral Valve Disease, Surgical Grand Rounds, Brookdale Hospital Medical Center, Brooklyn, NY, November 7, 2002.
PROFESSIONAL SOCIETIES
New York Society of Thoracic Surgery – Program Committee American College of Surgeons, Associate Member Michigan Chapter, American College of Surgeons University of Michigan Alumni Association
|